Predict your next investment


See what CB Insights has to offer



Date of IPO


About Selway Capital Acquisition Corp.

Selway Capital Acquisition Corporation is a publicly traded blank check company formed for the purpose of acquiring or merging with an operating business. Selway is seeking to merge with a business with the scale, profitability and growth potential to be a successful publicly-traded company. The company's capital is intended to enable growth whether through expansion, new product development, or expanded market presence.

Selway Capital Acquisition Corp. Headquarter Location

74 Grand Ave 2nd Floor

Englewood, New Jersey, 07631,

United States


Latest Selway Capital Acquisition Corp. News

Selway Capital Acquisition Corporation Announces New Trading Symbol

Sep 9, 2013

Sep 09, 2013, 12:50 ET from Selway Capital Acquisition Corporation NEW YORK, Sept. 9, 2013 /PRNewswire/ -- Selway Capital Acquisition Corporation (OTC: SWEL) ("Selway") today announced that the new class of common stock created by the consolidation of Selway's Series B shares of common stock and Series C shares of common stock into a single class of common stock will trade under the new trading symbol SWEL. Selway expects its common stock to begin trading under the new trading symbol as of the beginning of trading today, September 9, 2013. About Selway Capital Acquisition Corporation Following the consummation of Selway's acquisition of Healthcare Corporation of America ("HCCA") on April 10, 2013, Selway operates through HCCA. Based in Denville, N.J., HCCA's ( ) mission is to reduce prescription drug costs for clients while improving the quality of care for its members. Through its pharmacy benefit management (PBM) subsidiary, Prescription Corporation of America, HCCA administers prescription drug benefit programs for employers ranging from commercial clients of various sizes and industries to business associations and trade groups, as well as local government entities, labor unions, charitable and non-profit organizations, and third-party administrators of self-insured benefit plans. In addition, through its 340Basics subsidiary ( ), HCCA provides software and services to help Covered Entities manage all processes related to the Federal 340B Drug Discount Program including registration, compliance, audit, claims processing, and access to pharmacies. Contact: Yoram Bibring, Chief Financial Officer (973) 983-6300

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.